Summary
Stage I lung cancer patients were benefited by intrapleural treatment with 107 colony-forming units of Tice-strain BCG. This improvement was dependent upon a negative tuberculin test prior to therapy.
The research for this study was supported in part by the New York State Kidney Disease Institute, Division of Laboratories and Research, an agency of the New York State Department of Health, National Cancer Institute grant R01-CA-27039, and contract N01-CB-53940
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Gehan E (1965) A generalized two-sample Wilcoxon test for doubly censored data. Biometrika 52:650–653
Israel L, Mugica J, Chahinian PH (1973) Prognosis of early bronchogenic carcinoma. Survival curves of 451 patients after resection of lung cancer in relation to the results of preoperative tuberculin skin test. Biomedicine 19:68–72
Lowe J, Shore DF, lies PB, Langman MJS, Baldwin RW (1980) Intrapleural BCG in operable lung cancer. Lancet 1:11–14
Martini N, Beattie EJ Jr (1977) Results of surgical treatment in stage I lung cancer. J Thorac Cardiovasc Surg 74:499–505
McKneally MF, Payne WS (1978) Pulmonary neoplasms: Malignant and benign. In: Effler DB (ed) Blades’ surgical diseases of the chest, 4th edn. Mosby, St. Louis, pp 117–144
McKneally MF, Maver C, Kausel HW (1976) Regional immunotherapy of lung cancer with intrapleural BCG. Lancet 1:377–379
McKneally MF, Maver C, Kausel HW, Alley RD (1976) Regional immunotherapy with intrapleural BCG for lung cancer. J Thorac Cardiovasc Surg 72:333–338
Mountain CF (1977) Assessment of the role of surgery for control of lung cancer. Ann Thorac Surg 24: 365–373
Wright PW, Hill LD, Peterson AV, Bernstein ID (1980) Host response to purified protein derivative of tuberculin predicts outcome in patients receiving intrapleural bacillus Calmette-Guerin and levamisole for resectable, non-small cell lung cancer. Proc Am Assoc Cancer Res 21: 230
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Maver, C., Kausel, H., Lininger, L., McKneally, M. (1982). Intrapleural BCG Immunotherapy of Lung Cancer Patients. In: Mathé, G., Bonadonna, G., Salmon, S. (eds) Adjuvant Therapies of Cancer. Recent Results in Cancer Research, vol 80. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81685-7_36
Download citation
DOI: https://doi.org/10.1007/978-3-642-81685-7_36
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-81687-1
Online ISBN: 978-3-642-81685-7
eBook Packages: Springer Book Archive